QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=61540D4239DB999C5F159137709E572D;jsessionid=88FE384924ADAFEF26D62B024E3B40FD;jsessionid=12A20DD4D34E6E8518989F2F3D2DE4E6;jsessionid=BF360892DBF3717BC0EEE816C2A05B98;jsessionid=DECD2DFCCDA5E4F6ADE624C847B82FAC (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=61540D4239DB999C5F159137709E572D;jsessionid=88FE384924ADAFEF26D62B024E3B40FD;jsessionid=12A20DD4D34E6E8518989F2F3D2DE4E6;jsessionid=BF360892DBF3717BC0EEE816C2A05B98;jsessionid=DECD2DFCCDA5E4F6ADE624C847B82FAC